Connect Biopharma Holdings Limited
CNTB · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $41 | $78 | $110 | $106 |
| Short-Term Investments | $31 | $15 | $0 | $13 |
| Receivables | $0 | $1 | $4 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $2 | $2 | $2 |
| Total Curr. Assets | $78 | $97 | $116 | $121 |
| Property Plant & Equip (Net) | $5 | $4 | $5 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $5 | $4 | $5 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $83 | $101 | $121 | $126 |
| Liabilities | – | – | – | – |
| Payables | $2 | $0 | $6 | $8 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $13 |
| Other Curr. Liab. | $8 | $8 | $4 | $16 |
| Total Curr. Liab. | $11 | $8 | $10 | $24 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $1 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | -$3 |
| Other NC Liab. | $0 | $1 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $0 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $0 |
| Total Liabilities | $11 | $9 | $10 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$369 | -$345 | -$532 | -$539 |
| AOCI | -$1 | -$2 | $13 | -$8 |
| Other Equity | $441 | $439 | $629 | $629 |
| Total Equity | $71 | $92 | $110 | $101 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $83 | $101 | $121 | $126 |
| Net Debt | -$39 | -$78 | -$110 | -$106 |